Emily Waltz. Show Affiliations »
Abstract
Mesh: See more » Biomedical Research/economicsBiomedical Research/legislation & jurisprudenceBiotechnology/economicsBiotechnology/legislation & jurisprudenceCost-Benefit AnalysisDrug Industry/economicsDrug Industry/legislation & jurisprudenceFinancing, GovernmentHealth Services AccessibilityNational Institutes of Health (U.S.)/economicsResearch Support as Topic/legislation & jurisprudenceTreatment OutcomeUnited StatesUnited States Government Agencies/economics
Year: 2009 PMID: 19270651 DOI: 10.1038/nbt0309-211
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908